According to RAPT Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.69. In 2022 the company made an earnings per share (EPS) of -$2.58 a decrease over its 2021 EPS that were of -$2.53.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.69 | 4.26% |
2022 | -$2.58 | 1.98% |
2021 | -$2.53 | 15.53% |
2020 | -$2.19 | -84.66% |
2019 | -$14.28 | 584.41% |
2018 | -$2.09 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -18.96% | ๐บ๐ธ USA |